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Abstract 45 
Background 46 
The adult mammalian heart has little regenerative capacity after myocardial infarction (MI) 47 
while neonatal mouse heart regenerates without scarring or dysfunction. However, the 48 
underlying pathways are poorly defined. We sought to derive insights into the pathways 49 
regulating neonatal development of the mouse heart and cardiac regeneration post-MI. 50 
Methods and Results 51 
Total RNA-seq of mouse heart through the first 10 days of postnatal life (referred to as P3, P5, 52 
P10) revealed a previously unobserved transition in microRNA expression between P3 and P5 53 
associated specifically with altered expression of protein-coding genes on the focal adhesion 54 
pathway and cessation of cardiomyocyte cell division. We found profound changes in the 55 
coding and non-coding transcriptome after neonatal MI, with evidence of essentially complete 56 
healing by P10. Over two thirds of each of the mRNAs, lncRNAs and microRNAs that were 57 
differentially expressed in the post-MI heart were differentially expressed during normal 58 
postnatal development, suggesting a common regulatory pathway for normal cardiac 59 
development and post-MI cardiac regeneration. We selected exemplars of miRNAs implicated 60 
in our data set as regulators of cardiomyocyte proliferation. Several of these showed evidence 61 
of a functional influence on mouse cardiomyocyte cell division. In addition, a subset of these 62 
microRNAs, miR-144-3p, miR-195a-5p, miR-451a and miR-6240 showed evidence of 63 
functional conservation in human cardiomyocytes. 64 
Conclusions 65 
The sets of mRNAs, miRNAs and lncRNAs that we report here merit further investigation as 66 
gatekeepers of cell division in the postnatal heart and as targets for extension of the period of 67 
cardiac regeneration beyond the neonatal period. 68 
  69 
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Background 72 
Heart disease is amongst the commonest causes of death worldwide1. Whilst planarians, teleost 73 
fish and some amphibians have the ability to regrow limbs or organs including the heart2-4, 74 
mammals are limited in their regenerative abilities5,6. Following myocardial infarction (MI), 75 
damaged myocardium is replaced by scar tissue triggering cardiac remodelling and impaired 76 
cardiac function7,8. 77 
A major barrier to cardiac regeneration in adult mammals is the withdrawal of the 78 
cardiomyocyte from the cell cycle in early postnatal life. In the mouse, although DNA 79 
replication continues in the first week of postnatal life, cytokinesis ceases. By the second week 80 
of life, mouse cardiomyocytes withdraw from the cell cycle, 90% of cardiomyocytes are 81 
binucleated and, aside from a recent report of a proliferative burst at P159, recently contested10, 82 
heart growth after the first week of life occurs mainly through cardiomyocyte hypertrophy 83 
rather than proliferation11,12. This programme of cell cycle arrest is hypothesised to result from 84 
metabolic, physiological and anatomical changes in the first week of life including a shift to 85 
oxidative metabolism with relative hyperoxia compared to foetal life, increasing ventricular 86 
pressure and accumulation of extracellular matrix13. These considerations raised the possibility 87 
that regeneration of the mouse heart could follow cardiac injury in the immediate neonatal 88 
period and indeed complete cardiac regeneration has recently been demonstrated following 89 
apex resection and infarction of the mouse left ventricle (LV) on the first day of postnatal life14-90 
16. 91 
Transcriptome analyses in planarians and amphibians have yielded significant insights into the 92 
regulatory mechanisms underlying tissue and organ regeneration in these species17-19 but 93 
morphological, physiological and genetic differences between these species and mammals 94 
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limit the translational potential for application to human disease. They do, however provide the 95 
basis of the molecular investigations in mammals19. In mice, the role of individual microRNAs 96 
(miRNAs) and protein-coding messenger RNAs (mRNAs) have been defined by genetic 97 
analyses and gene targeting of specified mRNAs and miRNAs16,20,21. More recently with 98 
recognition of the functions of other RNA species, certain long non-coding RNAs (lncRNAs) 99 
have been implicated in cardiac biology22, for example, in protection from cardiac hypertrophy, 100 
foetal heart development, and autophagic cell death in myocardial infarction23-26. Although 101 
previous genome-wide studies have examined the coding transcriptome in neonatal and 102 
regenerating heart following apical resection27, genome-wide changes in the non-coding 103 
transcriptome have not been reported. 104 
Here we have performed an in-depth analysis of the coding and non-coding mouse LV 105 
transcriptome by RNA sequencing at key time points in early postnatal mouse heart 106 
development and in the LV during the period of regeneration following neonatal ligation of the 107 
left anterior descending coronary artery (LAD). The study defines the major sets of coding and 108 
non-coding RNAs associated with normal postnatal cardiac development and with regeneration 109 
of the neonatal heart following MI. We perform functional studies on a key set of exemplar 110 
miRNAs in mouse and human cardiomyocytes and identify conserved roles for these miRNAs 111 
in mammalian cardiomyocyte proliferation and mitosis. Our study provides new insights into 112 
the transcriptional regulation of neonatal cardiac development and regeneration in mammals 113 
that will be of value in future comparative and human intervention studies of cardiac 114 
regeneration. 115 
Materials and Methods 116 
The data, analytic methods, and study materials have been made available to other researchers 117 
for purposes of reproducing the results or replicating the procedure. They have been made 118 
publicly available at the Annotare, accession number E-MTAB-6272. All animal experiments 119 
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were performed in accordance with the Austrian Ethical Board, the Imperial College and the 120 
UK Home Office guidelines. 121 
Left anterior descending artery (LAD) ligation was performed in P0.5 neonatal C57BL6J mice, 122 
as previously described [15]. Left ventricle (LV) was harvested from three C57BL6J mice from 123 
sham-operated and LAD-ligated animals at three, five, seven and 10-days post ligation. Left 124 
ventricle (LV) was also harvested from three C57BL6J mice at P1, P3, P5, P7, P10 (referred 125 
to as physiological time points) in which no surgical procedures had been performed. Coding 126 
and non-coding RNA-Seq libraries were prepared using Illumina TruSeq stranded RNA library 127 
preparation and TruSeq small RNA library preparation kits following manufacturers’ 128 
protocols. Mouse genome assembly GCRm38/mm10 and the Ensembl transcript annotations 129 
(version GRCm38.87) were used as the reference sequence in all the analyses. RNA-Seq reads 130 
were quantified using Salmon (v.0.8.2)28. Differential expression (DE) analysis was performed 131 
using DESeq2 Bioconductor package. Raw p values were adjusted for multiple testing with the 132 
Benjamini-Hochberg procedure. Weighted gene co-expression cluster analysis (WGCNA) and 133 
a short timer series expression miner (STEM) analysis were performed to identify clusters of 134 
co-expressed mRNAs. Enrichment of KEGG Pathways for DE mRNAs was calculated using 135 
DAVID (v6.8) across all pairwise comparisons. MiRNA-Seq reads were aligned with Bowtie 136 
and MirDeep2 was used to determine the presence and quantity of miRNAs based on mouse 137 
precursor sequences and mature sequences from mouse and rat with miRBase release 19. 138 
MiRNA binding sites were predicted in-silico across each gene using the union of five separate 139 
prediction methods. Correlation matrices were generated between mRNAs and miRNAs and 140 
between mRNAs and lncRNAs. Potential functional relationships were identified by Spearman 141 
correlation, adjusted for multiple testing correction at FDR < 0.05. P5 mouse cardiomyocytes 142 
were treated with mmu-miR-22-5p, mmu-miR-144, mmu-miR-148a-3p, mmu-miR-193a-3p, 143 
mmu-miR-193b-3p, mmu-miR-221-3p, mmu-miR-331-3p, mmu-miR-451a inhibitors and 144 
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mmu-miR-6240 mimic and iCell® Cardiomyocytes were treated with human analogues of 145 
these miRs. Cells were incubated 10 µM EdU 4 h after seeding and subsequently fixed with 146 
4% paraformaldehyde and permeabilized in 0.2% (v/v) Triton X-100 before incubation with 147 
Click-iT reaction. Hoechst was used for nuclear staining and pH3 to mark mitotic cells. The 148 
analysis was then performed with conventional epifluorescence microscopy. 149 
Results 150 
To define the transcriptional changes occurring during physiological postnatal cardiac 151 
development and after neonatal MI, we generated RNA-Seq expression data of the coding and 152 
non-coding transcriptome from triplicate LV tissue harvested from C57BL/6 mice on postnatal 153 
day 0.5, 3.5, 5.5, 7.5 and 10.5, referred to as P1, P3, P5, P7 and P10, and from LV at 3 to 10 154 
days following LAD ligation (Figure 1). 155 
Transcriptional changes in coding RNA 156 
During the time course of physiological postnatal growth from P1 to P10, we identified 9,450 157 
unique differentially expressed (DE) mRNAs across all possible pairwise comparisons 158 
(Supplemental Table 1). 159 
We identified an increase in gene expression of 11 cardiomyocyte markers at different time 160 
points and an increase in cardiac fibroblast marker (Ddr2) after P5, reflecting the change in 161 
cellular composition within the LV (Supplemental Figure 1). WGCNA and STEM analyses of 162 
these genes identified clusters enriched for focal adhesion (p-adj = 1.22E-13), DNA replication 163 
(5.47E-16), ribosome (1.64E-50) and OXPHOS (p-adj = 0.013) pathways of KEGG analysis 164 
(Supplemental Figure 2A, B). These results were affirmed in pairwise comparisons between 165 
time points, with enrichment for DNA replication genes between P1 and P5, oxidative 166 
phosphorylation, focal adhesion genes between P3 and P10, and ribosomal transcripts 167 
throughout a 10-day period (Figure 2A, Supplemental Table 2). Investigation of pairwise 168 
comparisons between adjacent time points revealed a sharp increase in the number of 169 
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differentially expressed genes (DEG) from between P3 to P5 (494) to P5 to P7 (3,545), with 170 
the largest number identified between P7 and P10 (4,375) (Figure 2B, Supplemental Figure 171 
3A). Of the 40 most DEG between P5 and P7, 10 genes (Ube2c, Kif20a, Top2a, Racgap1, 172 
Cdca3, Cenpf, Ccna2, Iqgap3, Anln, Ccnb1 and CenpE) had GO terms associated with mitotic 173 
cell cycle process all of which were downregulated between P5 and P7 (Figure 2C, 174 
Supplemental Figure 2B). 175 
Following sham operation and LAD ligation, transcriptome analysis showed a large number of 176 
DEG between sham-operated and LAD-ligated mice three days after injury (shamvLAD (P3) 177 
= 2,741). The number of DEG declined very sharply three days post ligation, with 499 genes 178 
found to be DE between sham and LAD at P5, 112 between sham and LAD at P7, and 61 179 
between sham and LAD-ligated at P10 (Figure 2D, Supplemental Figure 3B). Upregulation of 180 
sarcomere expressed Mypn and cardiac fibroblast marker Ddr2 was observed following LAD 181 
ligation at P3 with restoration of physiological expression profile of cardiomyocyte markers 182 
from P7 (Supplemental Figure 1B). 183 
STEM analysis of the post-LAD ligation data showed 15 statistically significant profiles of 184 
changing gene expression, which had generally decreasing gene expression related to immune 185 
processes such as phagosome (p-adj = 5.9E-9) and cytokine-cytokine receptor interaction (p-186 
adj=8.77E-8) (Supplemental Figure 2C). Four profiles (40, 42, 48 and 49) showed increasing 187 
gene expression pattern and were significantly enriched for OXPHOS which was also observed 188 
in the WGCNA analysis (Supplemental Figure 2C, D). STEM analysis of mRNA expression 189 
in the sham-operated mice (P3-P10) showed pathway enrichment for 13 profiles, mirroring 190 
enrichments observed in the physiological samples. 191 
Consistent with the STEM annotation analysis, pairwise comparisons of the sham and LAD 192 
data at P3 showed that the major classes of DEG between P3 sham and LAD were within 193 
OXPHOS and lysosome pathways (Figure 2E, Supplementary Table 4). Of the top 40 most 194 
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significant DE mRNAs, we identified five genes (Fn1, Col1a1, Tnc, Thbs1 and Col1a2) with 195 
an increase in expression between sham and LAD at P3 that are implicated in focal adhesion 196 
pathways and three genes (Cd68, Laptm5 and Atp6v0d2) representing lysosome pathways 197 
(Figure 2E, F). Strikingly, 74% of the 3,210 genes that were DE between sham and LAD were 198 
also DE in the pairwise comparisons in the normal physiological data (Figure 2G). Of the 199 
10,284 DEG, 20 were validated and further characterised by qPCR across all conditions used 200 
in the study using an independent set of triplicate samples (Supplementary Figure 4A). 201 
Changes in non-coding RNA transcriptome 202 
Next, we analysed changes in the expression of non-coding RNAs including lncRNAs and 203 
miRNAs in the normal developing heart. Between all pairwise time point comparisons from 204 
P1 to P10, we identified 545 unique DE lncRNAs (Supplementary Table 1). A fourfold increase 205 
in the number of DE lncRNAs was observed between P3 and P5 (n=24) and between P5 and 206 
P7 (n=107) comparisons (Figure 3A). Only 59 of 545 DE lncRNAs have assigned names, for 207 
the remainder, there has been limited, functional characterisation. Four DE lncRNAs between 208 
P5vP7, within the top 40 DE, that have names and functions associated with them include: 209 
Nespas, Sorbs2os, H19 and Lockd (Figure 3B, Supplementary Table 1). This is the first report 210 
showing DE of any of these lncRNAs in the postnatal mammalian heart. 211 
To explore potential interactions between lncRNAs and mRNAs in the developing heart, we 212 
tested for correlation between lncRNA and mRNA expression across P1 to P10 time points. Of 213 
the 545 DE lncRNAs, 491 correlated significantly (p-adjSpearman < 0.05) with between 1 and 214 
2,604 mRNAs either in cis or trans. Overall, we found that there were slightly more (median 215 
= 26) lncRNAs significantly correlating in trans compared to in cis (median = 15), implying 216 
that their regulatory potential is not limited by chromosomal location (Figure 3C). 217 
To determine possible functional regulatory roles of DE lncRNAs, we performed a KEGG 218 
analysis on the sets of genes correlating in cis or trans with DE lncRNAs. We identified 86 219 
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lncRNAs that correlated significantly with gene sets enriched for the ribosome pathway, 113 220 
for oxidative phosphorylation, and 103 with enrichment for the focal adhesion pathway 221 
(Supplementary Table 3). 222 
Between sham-operated and LAD-ligated LV at P3 we identified 51 DE lncRNAs, 55 DE 223 
lncRNA at P5 and eight DE lncRNAs at P7. No DE lncRNAs were identified at P10 (Figure 224 
3E, Supplementary Table 1), in keeping with the marked reduction in DE mRNAs and miRNAs 225 
at later time points. The 51 DE lncRNAs between sham and LAD comparisons at P3 include 226 
the known lncRNAs H19, Dnm3os, Lockd, Malat1, Meg3, Mhrt, Mirt1, Neat1, Slmapos2, 227 
Zfp469 and 41 lncRNAs with unknown function (Figure 3E). A selection of these lncRNAs 228 
was significantly correlated with gene sets enriched in ribosome, OXPHOS, focal adhesion, 229 
lysosome and phagosome KEGG pathways (Supplementary Table 3). Seventy three of the 109 230 
DE lncRNAs (67%) between sham and LAD were also DE between time points in the 231 
physiological samples (Figure 3F, Supplementary Table 3). 232 
Analysis of small RNAs identified 413 DE miRNAs across all pairwise comparisons of 233 
physiological time points (Supplementary Table 4). Expression of 22 of 413 DE miRNAs was 234 
tested in separate samples from different animals, in all time points by qPCR and these were 235 
all validated (Supplementary Figure 4B). The changes were also validated in sorted cells’ 236 
subpopulations, showing that the change of expression occurred both in cardiomyocytes and 237 
endothelial cells (data not shown). Of the 413 DE miRNAs, 240 were DE between the P3vP5 238 
time points, 197 were unique (Figure 4A, Supplementary Table 4). The marked transition in 239 
expression of these miRNAs, between P3 and P5, has not previously been observed. 240 
To identify the potential roles of DE miRNAs during the P1 to P10 time period, we examined 241 
the correlation between the 413 miRNAs that were DE between all the time points and all 242 
mRNAs expressed in these samples, and intersected these data with the in silico predicted 243 
binding partners of the DE miRNAs to give a set of RNAs that correlate with and may be 244 
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targeted by these miRNAs (Supplementary Figure 5). We identified 65 unique miRNAs where 245 
their significantly correlated gene targets are enriched for specific KEGG pathways, 34 of 246 
which target a total of 67 genes associated with the focal adhesion pathway (Supplementary 247 
Table 5). Interestingly, orthologues of 49 of these 65 miRNAs were also identified in the human 248 
genome and these showed conservation of gene targets for a median of 84% of the orthologous 249 
genes within the human pathways (Supplementary Table 5). 250 
We also investigated the temporal relationship between miRNAs and mRNAs. The 240 DE 251 
miRNAs, identified between P3 and P5, are predicted to target 2,731 mRNAs. Of these 252 
mRNAs, we observed a significant overlap with 222 of 494 of DE mRNAs between P3 and P5 253 
(OR=2.09, p=7.51e-15) and 1,091 of the 3,545 DE mRNAs between P5 and P7 (OR=1.18, 254 
p=3.79e-4). 255 
Small RNA-seq analysis showed 153 DE miRNAs between sham and LAD three days post 256 
ligation, followed by a marked decline in the number of DE miRNAs between sham and LAD 257 
at later time points (Figure 4D). The top 40 significantly DE miRNAs between sham and LAD 258 
at P3 have not been previously reported as DE following LAD ligation (Figure 4E). The 153 259 
DE miRNAs identified between sham and LAD at P3 are predicted to target 2,231 mRNAs. Of 260 
these 2,231 mRNAs, 1,090 overlap with the 2,741 DE mRNAs identified between sham and 261 
LAD at P3 (OR=2.06, p<2.2e-16). 262 
Of the 39 DE miRNAs that correlated with and have predicted targets amongst the DE mRNAs, 263 
14 miRNAs target gene sets of between 9 and 314 genes in pathways for cancer, and 14 264 
miRNAs target between 13 and 23 mRNAs in focal adhesion (Figure 4E, Supplementary Table 265 
5). Interestingly, 31 of 39 miRNAs were conserved in humans and targeted a median of 75.7% 266 
of the orthologous genes in corresponding human pathways. Mirroring the mRNA data, 83% 267 
of the miRNAs that were DE between sham and LAD were also DE in the pairwise 268 
comparisons between the physiological time points (Figure 4F). 269 
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Functional analysis of miR inhibition and overexpression in P5 mouse cardiomyocytes 270 
To test the functional effects of miRNAs on cardiomyocyte proliferation we performed 271 
inhibition and overexpression studies in mouse and human cardiomyocytes, on a set of 272 
miRNAs that exhibited significant changes in physiological and pathological conditions and 273 
correlated with changes in mRNA in focal adhesion pathway We obtained over 80% reduction 274 
of the expression of nine miRNAs in primary mouse cardiomyocytes and a subset of four of 275 
their human orthologues in iCell® cardiomyocytes, and over 50% overexpression of miR-6240 276 
(data not shown). qRT-PCR analysis of the expression of cell cycle-regulating cyclins revealed 277 
that the levels of Ccna2, CcnD2 and CcnE2 increased significantly (> 2-fold) following 278 
treatment with miR-22-5p, miR-451a and miR-195a inhibitors, and with miR-6240 mimic, in 279 
comparison to cells treated with scramble (p < 0.05) (Figure 5A). Treatment with seven other 280 
miR inhibitors did not result in any significant changes (p > 0.05) of tested cyclins expression 281 
(Figure 5A). Expression of Ccna1, CcnD1, CcnD3 and CcnE1 did not change in response to 282 
inhibition or overexpression of any of the miRNAs. 283 
To determine whether inhibition or overexpression of these miRs plays a direct role in 284 
promoting cardiomyocyte proliferation we measured the nuclear incorporation of EdU (S-285 
phase marker) and pH3 staining (mitosis marker) in P5 mouse cardiomyocytes. A marked 286 
increase in proliferating (EdU positive) cells (up to 5-fold) was observed for cardiomyocytes 287 
treated with miR-22-5p, miR-144-3p, miR-148a-3p, miR-193a-3p, miR-193b-3p, miR-195a-288 
5p, miR-221-3p, miR-331-3p, miR-451a inhibitors and miR-6240 mimic (Figure 5B). 289 
Likewise, an increase of mitotic (pH3 positive) cells was seen (up to 3-fold), following 290 
treatment with miR-22-5p, miR-195a-5p and miR-451a inhibitors and miR-6240 mimic 291 
(Figure 5C, Supplementary Figure 6A). Scramble-treated mouse cells served as the negative 292 
control for both assays. 293 
Functional analysis of selected miRs in human cardiomyocytes 294 
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Given our data showing that several miRNAs regulate aspects of proliferation in P5 mouse 295 
cardiomyocytes, we tested whether the human orthologues of these miRNAs can functionally 296 
regulate cardiomyocyte proliferation in iCell® cardiomyocytes. We transfected iCell® 297 
cardiomyocytes with a subset of human miR inhibitor and mimic orthologues that we had 298 
previously tested in mouse cardiomyocytes. qRT-PCR analysis of cyclins expression revealed 299 
elevated levels of Ccna2, CcnD2 and CcnE2 in miR-22-5p, miR-451a and miR-6240 treated 300 
cells in comparison with scramble treatment (p < 0.05) (Figure 5D). As with the mouse miR 301 
interventions, levels of Ccna1, CcnD1, CcnD3 and CcnE1 were unchanged (Figure 5D). iCell® 302 
cardiomyocytes treatment with miR-6240 mimic showed an increase in number of proliferating 303 
cells and treatment with miR-144-3p, miR-195a-5p, miR-451a and miR-6240 showed up to a 304 
2–fold increase in the number of mitotic cells (Figure 5E, F, Supplementary Figure 6B). 305 
Discussion 306 
We set out to define the programme of the coding and non-coding transcriptome in the healthy 307 
neonatal heart during the period of loss of regenerative capacity and to relate this to the 308 
transcriptional changes associated with cardiac regeneration following neonatal MI. We found 309 
a sharp transition in microRNA expression in the developing heart between P3 and P5 310 
associated with subsequent changes in expression of genes on the focal adhesion pathway and 311 
cardiomyocyte division arrest. We mapped profound changes in the transcriptome that returned 312 
to normal within 10 days following neonatal MI, indicating essentially complete healing of the 313 
myocardium by this time point, confirming our previous findings15. We showed that two thirds 314 
of all RNA species that were DE in the post-MI heart were also DE during normal postnatal 315 
development, suggesting a common regulatory pathway for normal post-natal cardiac 316 
development and post-MI regeneration. Finally, we demonstrated that miR-144-3p, miR-195a-317 
5p and miR-451a inhibition and miR-6240 activation have functionally conserved roles in cell 318 
proliferation and mitosis in mouse and human cardiomyocytes. 319 
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We found that the first 10 days of postnatal life were associated with alterations in gene 320 
expression of thousands of genes, particularly those encoding proteins involved in cell cycle 321 
progression at early time points, oxidative phosphorylation at later time points and protein 322 
translation throughout. These enriched pathways are likely reflective of changes in ventricular 323 
pressure, transition from hypoxic to the oxygen rich postnatal environment with increased 324 
reliance on oxidative metabolism, and changes in cellular architecture and the extracellular 325 
matrix between P3 and P713,29. During the P5 and P7 time window, one quarter of the most 326 
DEG correspond to GO terms associated with M-phase mitosis and mitotic cell cycle 327 
checkpoint, including Cdk130, Ccna231, Cdc1332 and Bub133, in keeping with the withdrawal 328 
of cardiomyocytes from DNA replication and cell division at this time point. While the relative 329 
abundance of myocytes, cardiac fibroblasts, endothelial cells and vascular smooth muscle cells 330 
change in the LV during the first ten postnatal days34 and ontologies and pathways identified 331 
through our transcriptomic study are in part reflective of this, we were able to identify putative 332 
drivers of cardiomyocyte proliferation and functionally validate them in mouse primary cells 333 
and human cardiomyocyte cell line. 334 
We found major differences in mRNA, miRNA and lncRNA expression between LAD-ligated 335 
and sham-operated mice three days following MI, but these differences had almost completely 336 
resolved within seven days of LAD ligation and increased gene expression of cardiomyocyte 337 
markers is restored to mirror closely the physiological gene expression changes. At the 338 
transcriptional level, therefore, the regenerative process was essentially complete by P10, 339 
although certain developmental and cardiac failure markers, like Nppa35, remained elevated. 340 
The most profoundly DEG three days post LAD were those involved in immune processes, 341 
similarly shown in the contrasting model of heart regeneration following apex removal together 342 
with cell cycle progression and RNA synthesis27 and oxidative phosphorylation, in keeping 343 
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with previous observations of the importance of an active immune response in physiological 344 
regulation of cardiac regeneration in mice36,37. 345 
Similar changes in expression were observed with lncRNAs, where of the 107 DE lncRNAs 346 
between P5 and P7, only seven, including H19 and Neat1, have proposed functions, in cell 347 
proliferation38-40, and none have been previously associated with postnatal heart development 348 
or regeneration. We also found evidence for trans-regulation of expression by lncRNAs with 349 
enrichment amongst correlating gene sets on OXPHOS, ribosomes and focal adhesion 350 
pathways, and show significant enrichment for imprinting amongst DE lncRNAs. While 351 
previously described in other tissues41, enrichment for imprinted loci has rarely been observed 352 
previously in the postnatal heart or following MI42. 353 
We observed a profound shift in microRNA expression in the developing heart between P3 and 354 
P5 associated with an altered expression of genes on the focal adhesion pathway between P5 355 
and P7. Since genes and proteins on the focal adhesion pathway mediate the transduction of 356 
external stimuli such as increasing blood pressure or hypoxia29,43 44 into processes such as DNA 357 
replication and cell division45, we hypothesise that the set of miRNAs that were DE in the P3 358 
to P5 time window are key to the regulation of molecular events leading to withdrawal of the 359 
cardiomyocyte from cell division in the first week of life. To test this hypothesis, we performed 360 
in vitro inhibition and over-expression studies on 10 miRNAs which exhibited significant 361 
changes in physiological and pathological conditions. They include two miRNAs (miR-195a-362 
5p and miR-22-5p) for which previous evidence has been presented20,46. Our results 363 
demonstrate that the inhibition of miR-22-5p and miR-451a and miR-6240 up-regulation 364 
individually elevate the expression of CcnA2, CcnD2 and CcnE2 in P5 mouse and human 365 
cardiomyocytes leading to increased proliferation and cell division. We did not observe 366 
changes in expression of CcnA1 (expressed in germ cells), CcnE1 (lowly expressed in heart), 367 
CcnD1 or CcnD3 (low expression in tested cardiomyocytes) in comparison to scramble-treated 368 
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cells. Targets of miR-22 include Map2k1, Map3k9, Rock2 representing the focal adhesion 369 
pathway, regulation of cell proliferation, and Aurkb participating in the regulation of alignment 370 
and segregation of chromosomes during cell division47. miR-451a targets Tbx1 and Ybx1 371 
transcription factors regulating proliferation and differentiation of multipotent heart 372 
progenitors48 and is implicated in translational control of foetal myocardial gene expression 373 
after cardiac transplant49. There is limited knowledge on the functional role of miR-6240, and 374 
here we show for the first time, its function in cardiomyocyte proliferation and heart 375 
regeneration in mouse and human cardiomyocytes50. Interestingly, miR-22 has been previously 376 
found to be highly expressed in cardiac muscle, upregulated during myocyte differentiation 377 
which alone has been found to be sufficient to induce cardiomyocyte hypertrophy. 378 
Our study reports the transcriptional changes in the developing and post-MI postnatal heart and 379 
defines sets of mRNAs, miRNAs and lncRNAs that we propose to be the key regulators, at the 380 
level of the transcriptome, of withdrawal of the postnatal mouse heart from DNA replication 381 
and cell division. We also identify miR-144-3p, miR-195a, miR-451a and miR-6240 as 382 
functionally conserved, non-coding regulators of cardiomyocyte division in neonatal mouse 383 
and humans. Whilst we have not studied all the downstream consequences of our findings, 384 
including more detailed impact on protein, cell cycle, and in vivo validation, our work provides 385 
a platform for future studies. 386 
Recent progress in research in developmental cardiology has significantly advanced our 387 
understanding of heart development and regeneration51. Insights from zebrafish models of heart 388 
regeneration, following apex removal or cryosurgery, show that they are capable of myocardial 389 
regeneration mediated mainly through the proliferation of pre-existing gata4+ cardiomyocytes 390 
with miR-13352 and miR-10153, playing regulatory roles in this process, as also shown in our 391 
neonatal mouse data set. More recently, the attempt to pinpoint the regulatory hubs in zebrafish 392 
heart regeneration revealed a function of il6st, adam8, and cd63 19, also shown to be DE 393 
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expressed in our post-ligation data sets. Studies of heart regeneration in neonatal mice reported 394 
Myh7 and Igf1r as key drivers of gene interaction networks and pointing to C1orf61, Aif1, 395 
Rock1 as potential inhibitors of cardiomyocyte proliferation and G1/S phase transition54, genes 396 
that were also DE between physiological time points in our set. In addition, miRNAs from the 397 
miR-15 family20, miR-503-5p54, miR-199a55, miR-99/100 and Let7a/c21 were also reported as 398 
critical regulators of the regeneration process, which were also found as DE in our 399 
physiological and sham/LAD comparisions in our data set. Interleukin 13, DE in the 400 
regenerating neonatal heart in our data set, has also been identified as a regulator of 401 
cardiomyocyte cell cycle entry mediated by STAT3/periostin and STAT627. Whilst our data 402 
show considerable overlap with previous observations in mice and zebrafish, we provide a 403 
systematic and comprehensive analysis of coding and non-coding transcriptome changes over 404 
multiple time points of the first 10 days of postnatal life and after neonatal LAD ligation, which 405 
has not been available hitherto. 406 
In summary, we present a finely grained time course for mRNA, miRNA and lncRNA in the 407 
normal developing heart from postnatal day 1 (P1) to P10, and in the 3 to 10 days following 408 
neonatal MI. We found profound changes in the coding and non-coding transcriptome after 409 
neonatal MI, with evidence of essentially complete transcriptional healing by P10. We find a 410 
sharp transition in miRNA expression in physiological cardiac samples between P3 and P5, 411 
with differentially expressed miRNAs associated specifically with altered expression of genes 412 
on the focal adhesion pathway and cessation of cardiomyocyte division. Two thirds of each of 413 
the mRNAs, lncRNAs and microRNAs that were differentially expressed in the post-MI heart 414 
were also differentially expressed during normal postnatal development, suggesting a common 415 
regulatory pathway for normal cardiac development and post-MI cardiac regeneration. Of the 416 
miRNAs that we implicate in regulation of cardiomyocyte development and regeneration, 67% 417 
had targets that were conserved between mice and humans. We present a subset of miRNAs: 418 
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miR-451a, miR-6240, miR-195a-5p and miR-144-3p that showed functional evidence in vitro 419 
as regulators of cell division in mouse and/or human cardiomyocytes. 420 
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Figure legends 438 
Figure1. Experimental design. 439 
Overview of experimental design showing time points at which LV tissue was harvested (A) 440 
during physiological time points, and following LAD or sham operation. P1-10, postnatal days 441 
1-10; MI myocardial infarction, (B) sequencing pipeline and (C) functional investigation. All 442 
the experiments were performed in three individual animals for each time point and condition. 443 
 444 
 445 
Figure 2. Changes of mRNA expression in physiological LV and following MI. 446 
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All mRNA sequencing experiments and data analyses were performed in individual animals 447 
for each time point and condition. 448 
(A) KEGG pathway analysis between adjacent pairwise comparisons in physiological LV. (B) 449 
Venn diagram showing numbers of DE mRNAs between physiological pairwise comparison (C) Top 450 
40 DE mRNAs between P5 and P7, (D) DE transcripts between LAD and sham samples-pairwise 451 
comparison, (E) KEGG pathway analysis between LAD and sham samples is pairwise comparison, (F) 452 
Top 40 DE mRNAs between LAD and sham 3 days post-surgery, (G) Overlap between DE coding 453 
transcripts in physiological and MI LVs. 454 
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Figure 3. Changes of lncRNA expression in physiological LV and following MI. 458 
All lncRNA sequencing experiments and data analyses were performed in individual animals 459 
for each time point and condition. 460 
(A) Venn diagram showing numbers of DE lncRNAs between adjacent pairwise comparisons 461 
in physiological time points. (B) Top 40 most DE transcripts between P5 and P7. (C) The 462 
number of correlating DE mRNAs with DE lncRNAs in the increasing distance from 463 
transcription start site (TSS). (D) Numbers of DE lncRNAs following sham and LAD 464 
operations in pairwise comparisons. (E) Identities of the most DE lncRNAs between sham and 465 
LAD-operated LVs three days post-surgery. (F) Overlap between DE lncRNAs between 466 
physiological LVs and following surgery. 467 
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Figure 4. Changes of miRNA expression in physiological LV and following MI. 469 
All miRNA sequencing experiments and data analyses were performed in individual animals 470 
for each time point and condition. 471 
(A) Venn diagram showing numbers of DE miRNAs between adjacent pairwise comparisons 472 
in physiological time points. (B) Heat map showing 40 most DE expressed miRNAs. (C) Focal 473 
adhesion and growth factor pathways diagram showing the genes targeted by DE miRNAs. (D) 474 
Numbers of DE miRNAs following MI. (E) Heat map of the most DE miRNAs three days post 475 
MI. (F) Overlap between DE miRNAs between physiological LVs and following surgery. 476 
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Figure 5. Functional analysis of miR inhibition and overexpression in P5 mouse and human 479 
cardiomyocytes. 480 
Functional analysis experiments were performed in triplicates for each cell type and each 481 
transfection miRNA. 482 
(A) Changes in mRNA expression of cell cycle regulating cyclins in P5 mouse primary 483 
cardiomyocytes following treatment with miRNA inhibitors and mimic. A significance 484 
indicated by star. EdU and pH3 staining revealing number of proliferating (B) and dividing 485 
cells (C) following treatment with miRNAs. (D) Changes in mRNA expression of cell cycle 486 
regulating cyclins in human iPSC derived cardiomyocytes following treatment with miRNA 487 
inhibitors and mimic. EdU and pH3 staining revealing number of proliferating (E) and dividing 488 
cells (F) iPSC derived cardiomyocytes following treatment with miRNAs. 489 
A significance vs. scramble control indicated by stars as follows: *** p ≤ 0.001, ** p ≤ 0.01, * 490 
p≤ 0.05. 491 
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